Clinical Trial Update: Tamoxifen for the Prevention of Breast Cancer in High-Risk Women [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on tamoxifen for preventing breast cancer in high-risk women. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Queen Mary University of London | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED